Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Adapalene / Benzoyl Peroxide / Clindamycin · Cabtreo

Small molecule · Modulator of retinoic acid nuclear receptors and bacterial cell wall/membrane · developed by Bausch

Approved FDA, Oct 2023

BHC Developer

2 Registered trials

What is Adapalene / Benzoyl Peroxide / Clindamycin?

A topical combination gel containing clindamycin phosphate (lincosamide antibacterial), adapalene (retinoid modulator of cellular differentiation and keratinization), and benzoyl peroxide (oxidizing agent with bactericidal and keratolytic effects).

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as: Cabtreo
Drug type: Small molecule
Targets: retinoic acid nuclear receptors, bacterial cell wall/membrane
Mechanism: Modulator of retinoic acid nuclear receptors and bacterial cell wall/membrane
Pathways: cellular differentiation, keratinization, inflammatory processes
Therapy area: Dermatology
Developer: Bausch (BHC)
FDA status: Approved as Cabtreo (October 20, 2023), NDA216632 · FDA label

✅ FDA-approved uses

Acne vulgaris

From the indications section of the FDA label (version of Apr 24, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT07524946	Phase 4	Acne Vulgaris	Recruiting	BHC
NCT05582434	Early Phase 1	Acne	Active not recruiting	BHC

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

AcneAcne Vulgaris

More from Bausch

Brodalumab FDA approved Bupropion FDA approved Halobetasol Propionate And Tazarotene FDA approved IDP-118 FDA approved IDP-126 FDA approved Lifitegrast FDA approved Perfluorohexyloctane FDA approved Plecanatide FDA approved Rifaximin FDA approved Timolol FDA approved BL1107 Phase 2 BL1332 Phase 2

Sources

Updated Oct 3, 2026. Something wrong or missing? Report it on the BHC page.

Follow BHC, the company behind Adapalene / Benzoyl Peroxide / Clindamycin

See BHC's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

BHC catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z